Filter Results
:
(209)
Show Results For
-
All HBS Web
(1,801)
- Faculty Publications (209)
Show Results For
-
All HBS Web
(1,801)
- Faculty Publications (209)
- January 2009 (Revised February 2009)
- Case
Pitney Bowes: Employer Health Strategy
By: Michael E. Porter and Jennifer F Baron
Pitney Bowes, a Fortune 500 mail and document management firm, offered its first health plans in the years following World War II. Over the ensuing decades, Pitney Bowes adapted its approach to employee health amid rising health care costs, shifting employer attitudes...
View Details
Keywords:
Cost;
Insurance;
Policy;
Health Care and Treatment;
Compensation and Benefits;
Employees;
Corporate Strategy
Porter, Michael E., and Jennifer F Baron. "Pitney Bowes: Employer Health Strategy." Harvard Business School Case 709-458, January 2009. (Revised February 2009.)
- 2008
- Book
On Competition
By: M. E. Porter
Competition is one of society's most powerful forces for making things better in many fields of human endeavor. The study of competition and the creation of value, in their full richness, have preoccupied me for several decades. Competition is pervasive, whether it...
View Details
Porter, M. E. On Competition. Updated and Expanded Ed. Boston: Harvard Business School Publishing, 2008.
- July–August 2008
- Article
Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School, Cambridge, MA. She received her bachelor's degree from MIT and her doctorate from the Harvard Business School The first woman to be tenured and...
View Details
"Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare." Journal for Healthcare Quality 30, no. 4 (July–August 2008): 17–19.
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues.
View Details
Keywords:
Decision Choices and Conditions;
Financing and Loans;
Health Care and Treatment;
Health Disorders;
Medical Specialties;
Expansion;
Health Industry;
Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.
- June 2007
- Article
Efficient Kidney Exchange: Coincidence of Wants in a Structured Market
By: A. E. Roth, Tayfun Sonmez and M. Utku Unver
Patients needing kidney transplants may have donors who cannot donate to them because of blood or tissue incompatibility. Incompatible patient-donor pairs can exchange donor kidneys with other pairs only when there is a "double coincidence of wants." Developing...
View Details
Keywords:
Organizational Structure;
Size;
Emotions;
Human Needs;
Health Care and Treatment;
Health Testing and Trials;
Infrastructure;
Supply Chain Management;
Fairness;
Performance Improvement;
Health Industry
Roth, A. E., Tayfun Sonmez, and M. Utku Unver. "Efficient Kidney Exchange: Coincidence of Wants in a Structured Market." American Economic Review 97, no. 3 (June 2007): 828–851.
- Article
The Information Technology Ecosystem: Structure, Health, and Performance
By: Marco Iansiti and Gregory L. Richards
A number of modern industries are organized as complex networks of firms whose integrated efforts are necessary to deliver value to end customers. The complexity of these networks, or business ecosystems, and the associated interdependencies among firms, make... View Details
Keywords:
Business Ventures;
Networks;
Value;
Customers;
Performance Productivity;
Product;
Applications and Software;
Innovation and Invention;
Competition;
Business Model;
Information Infrastructure;
Information Technology Industry
Iansiti, Marco, and Gregory L. Richards. "The Information Technology Ecosystem: Structure, Health, and Performance." Antitrust Bulletin 51, no. 1 (Spring 2006).
- 2006
- Book
Confidence: How Winning Streaks and Losing Streaks Begin and End
Is success simply a matter of money and talent? Or is there another reason why some people and organizations always land on their feet, while others, equally talented, stumble again and again? There's a fundamental principle at work—confidence—that makes the difference...
View Details
Keywords:
Social Psychology
Kanter, Rosabeth M. Confidence: How Winning Streaks and Losing Streaks Begin and End. New York: Three Rivers Press, 2006. (Paperback edition with new Foreword, Epilogue, and Appendix.)
- November 2005 (Revised November 2005)
- Case
Massachusetts General Hospital and the Enbrel Royalty
By: David S. Scharfstein and Darren R. Smart
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well...
View Details
Keywords:
Valuation;
Price;
Investment Return;
Capital;
Value;
Revenue;
Health Care and Treatment;
Health Industry;
Health Industry;
Massachusetts
Scharfstein, David S., and Darren R. Smart. "Massachusetts General Hospital and the Enbrel Royalty." Harvard Business School Case 206-075, November 2005. (Revised November 2005.)
- July 2005 (Revised December 2006)
- Case
Japan: Deficits, Demography, and Deflation
By 2005, Japan's debt had risen to 163% of GDP. For more than a decade, the government had run huge deficits, trying unsuccessfully to stimulate economic growth. Interest rates, meanwhile, had been zero for years. But with slow growth and banks in crisis, nothing had...
View Details
Keywords:
Economy;
Economic Growth;
Demographics;
Financial Condition;
Inflation and Deflation;
Banks and Banking;
Borrowing and Debt;
Macroeconomics;
Policy;
Government and Politics;
Welfare;
Health Care and Treatment;
Japan
Vietor, Richard H.K. "Japan: Deficits, Demography, and Deflation." Harvard Business School Case 706-004, July 2005. (Revised December 2006.)
- December 2003 (Revised April 2004)
- Case
Dragon's Teeth Vineyards
By: Alan D. MacCormack, Marius Leibold, Sven Voelpel and Kerry Herman
Dragon's Teeth Vineyards (DTV) is a South African wine producer that is considering whether to use genetically modified organisms (GMOs) in its wine-making process. GMOs promise to lower the costs of wine production significantly through increased yields and reduced...
View Details
Keywords:
Technological Innovation;
Growth and Development Strategy;
Genetics;
Transition;
Brands and Branding;
Product Development;
Product Design;
Organizational Change and Adaptation;
Technology Adoption;
Food and Beverage Industry;
Biotechnology Industry;
South Africa
MacCormack, Alan D., Marius Leibold, Sven Voelpel, and Kerry Herman. "Dragon's Teeth Vineyards." Harvard Business School Case 604-069, December 2003. (Revised April 2004.)
- August 2003 (Revised July 2023)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
What can Dr. Dean Ornish learn from the successes and failures of his competitors in ameliorating morbid obesity to create a business model that will “do good” by combatting obesity and associated chronic diseases and “do well” by growing a widely adopted business?...
View Details
Keywords:
Three Pillars;
Industry Analysis;
Health Disorders;
Health Care and Treatment;
Innovation and Invention;
Business Model;
Analysis;
Innovation and Management;
Medical Specialties;
Mission and Purpose;
Health Industry
Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised July 2023.)
- June 2003 (Revised November 2003)
- Case
Siemens Medical Solutions: Strategic Turnaround
By: D. Quinn Mills and Julian Kurz
Describes how Siemens Medical Solutions (MED) accomplished a remarkable turnaround from a money-losing operation to one of Siemens' most profitable divisions. By late 1996, a challenging market environment in the health care industry as well as inefficiencies in the...
View Details
Keywords:
Opportunities;
Globalized Firms and Management;
Health Care and Treatment;
Transformation;
Problems and Challenges;
Medical Devices and Supplies Industry
Mills, D. Quinn, and Julian Kurz. "Siemens Medical Solutions: Strategic Turnaround." Harvard Business School Case 703-494, June 2003. (Revised November 2003.)
- March 2001 (Revised April 2001)
- Case
Montefiore Medical Center
By: Robert S. Kaplan and Syeda Noorein Inamdar
A large urban medical center implements the Balanced Scorecard management tool. Elaine Brennan, senior VP of operations, has reorganized a highly functional health care organization into decentralized patient care centers and support units. Having recently endured the...
View Details
Keywords:
Balanced Scorecard;
Health Care and Treatment;
Management Systems;
Organizational Structure;
Corporate Strategy;
Leadership Development;
Growth and Development Strategy;
Financial Reporting;
Budgets and Budgeting;
Cost Accounting;
Corporate Accountability;
Communication;
Health Industry
Kaplan, Robert S., and Syeda Noorein Inamdar. "Montefiore Medical Center." Harvard Business School Case 101-067, March 2001. (Revised April 2001.)
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to...
View Details
Keywords:
Product Development;
Marketing Strategy;
Health Testing and Trials;
Risk and Uncertainty;
Technological Innovation;
Innovation Strategy;
Science-Based Business;
Biotechnology Industry
Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
- July 2000 (Revised November 2001)
- Case
Catalyst Medical Solutions
By: Amy C. Edmondson, Richard M.J. Bohmer and Naomi Atkins
Faced with a drop in the NASDAQ, four eHealth entrepreneurs must decide between two distribution strategies for their new company's technology. The team, comprised of three full-time resident physicians and an MBA, has developed software to enable electronic...
View Details
Keywords:
Product Development;
Health Care and Treatment;
Distribution;
Strategy;
Venture Capital;
Applications and Software;
Partners and Partnerships;
Borrowing and Debt;
Information Technology Industry;
Service Industry
Edmondson, Amy C., Richard M.J. Bohmer, and Naomi Atkins. "Catalyst Medical Solutions." Harvard Business School Case 601-014, July 2000. (Revised November 2001.)
- March 2000
- Case
Heartport, Inc.
By: Gary P. Pisano and Shoshana Dobrow
Heartport, an entrepreneurial medical device maker, has introduced several innovative systems for conducting less-invasive cardiac surgery. Despite initially high expectations, the company has struggled to get its technology adopted by cardiac surgeons. The company's...
View Details
Keywords:
History;
Product Positioning;
Knowledge Acquisition;
Corporate Entrepreneurship;
Technology Adoption;
Health Care and Treatment
Pisano, Gary P., and Shoshana Dobrow. "Heartport, Inc." Harvard Business School Case 600-020, March 2000.
- March 1999
- Case
Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)
By: Michael Beer and Perry Fagan
In the early 1990s, Merck faced a series of challenges because of significant changes in its competitive and regulatory environment (e.g., growth in power of pharmaceutical buyers like managed care organizations led to price pressures and President Clinton's review of...
View Details
Keywords:
Organizational Change and Adaptation;
Business or Company Management;
Organizational Culture;
Problems and Challenges;
Management Practices and Processes;
Competitive Strategy;
Management Teams;
Health Care and Treatment;
Governing Rules, Regulations, and Reforms;
Situation or Environment;
Alignment;
Pharmaceutical Industry;
United States
Beer, Michael, and Perry Fagan. "Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)." Harvard Business School Case 499-054, March 1999.
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one...
View Details
Keywords:
Information Technology;
Organizational Structure;
Technological Innovation;
Business Processes;
Health Care and Treatment;
Performance Productivity;
Welfare;
Agribusiness;
Genetics;
Science-Based Business;
Biotechnology Industry;
Agriculture and Agribusiness Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- April 1998
- Case
Cephalon, Inc.
By: Peter Tufano
In early 1997, Cephalon, awaited an FDA panel's decision on whether its drug, Myotrophin, would be approved. If the drug was approved, the firm might need substantial additional funds to commercialize as well as to buy back rights to it (which had been sold earlier to...
View Details
Keywords:
Risk Management;
Financing and Loans;
Health Care and Treatment;
Pharmaceutical Industry;
United States
Tufano, Peter, Geoffrey Verter, and Markus Mullarkey. "Cephalon, Inc." Harvard Business School Case 298-116, April 1998.
- March 1992 (Revised March 1995)
- Case
Kevin Simpson
By: Linda A. Hill
Follows Kevin Simpson, a second-year Harvard Business School 1990 student, through his job search to his final decision between two very attractive but different job offers: a job as an international marketing manager at Eli Lilly and Co., a leading multinational...
View Details
Hill, Linda A. "Kevin Simpson." Harvard Business School Case 492-041, March 1992. (Revised March 1995.)